SCOPUS 정보 검색 플랫폼

Volumn 78, Issue 2, 2000, Pages 212-216

A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: A gynecologic oncology group study

(6) Rose, Peter G a Brunetto, Virginia L b VanLe, Linda c Bell, Jeffrey d Walker, Joan L e Lee, Roger B f

a UNIVERSITY HOSPITALS OF CLEVELAND (United States)

b ROSWELL PARK CANCER INSTITUTE (United States)

c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE (United States)

d OHIO STATE UNIVERSITY (United States)

e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE (United States)

f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; GOSERELIN; LEUPRORELIN; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; EDEMA; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME; UTERUS CANCER;

EID: 0033838806 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2000.5865 Document Type: Article

Times cited : (180)

References (29)

1
- 0021169529
- Progestin therapy of endometrial, breast and ovarian carcinoma
- (1984) ACTA Obstet Gynecol Scand , vol.63 , pp. 441-450
- Kauppila, A.¹

2
- 0018923111
- Medroxyprogesterone acetate (Depo-Provera) vs hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma
- (1980) Cancer , vol.45 , pp. 268-272
- Piver, M.S.¹ Barlow, J.J.² Lurain, J.R.³ Blumenson, L.E.⁴

3
- 0021843010
- Effects of progestational agents in treatment of endometrial carcinoma
- (1985) Obstet Gynecol , vol.66 , pp. 106-110
- Podratz, K.C.¹ O'Brien, P.C.² Malkasian, G.D.³ Decker, D.G.⁴ Jefferies, J.A.⁵ Edmonson, J.H.⁶

4
- 0002947450
- Oral medroxyprogesterone acetate in advanced or recurrent endometrial carcinoma: Results of therapy and correlation with estrogen and progesterone receptor levels
- The Gynecologic Oncology Group experience, in Baulieu EE, Slacobelli, McGuire WW (eds): Endocrinology and Malignancy. Park Ridge, NJ, Parthenon
- (1986) , pp. 446-454
- Thigpen, T.¹ Blessing, J.² Disaia, P.³ Ehrlich, C.⁴

5
- 0020035703
- Origin of serum estradiol in postmenopausal women
- (1982) Obstet Gynecol , vol.59 , pp. 680-686
- Judd, H.L.¹ Shamonki, I.M.² Frumar, A.M.³ Lagasse, L.D.⁴

6
- 0027997441
- Aromatase inhibitors in the treatment of breast cancer
- (1994) J Steroid Biochem Mol Biol , vol.49 , pp. 281-287
- Brodie, A.M.¹

7
- 0028990478
- Arimidex: A new oral, once-a-day aromatase inhibitor
- (1995) J Steroid Biochem Mol Biol , vol.53 , pp. 175-179
- Plourde, P.V.¹ Dyroff, M.² Dowsett, M.³ Demers, L.⁴ Yates, R.⁵ Webster, A.⁶

8
- 8944237006
- Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase III trials
- (1996) J Clin Oncol , vol.14 , pp. 2000-2011
- Budzar, A.¹ Jonat, W.² Buzdar, A.³ Howell, A.⁴ Jones, S.E.⁵ Blomqvist, C.⁶ Vogel, C.L.⁷ Eiermann, W.⁸ Wolter, J.M.⁹ Azab, M.¹⁰ Webster, A.¹¹ Plourde, P.V.¹²

9
- 0031054095
- A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma
- (1997) Cancer , vol.79 , pp. 730-739
- Budzar, A.U.¹ Jones, S.E.² Vogel, C.L.³ Wolter, J.⁴ Plourde, P.⁵ Webster, A.⁶

10
- 0032530988
- Anastrozole versus megestrol acetate in the treatment of postmenopansal women with advanced breast carcinoma. Results of a survival update based on a combined analysis of data from two mature phase III trials
- (1998) Cancer , vol.83 , pp. 1142-1152
- Budzar, A.U.¹ Jonat, W.² Howell, A.³ Jones, S.E.⁴ Blomqvist, C.P.⁵ Vogel, C.L.⁶ Eirmann, W.⁷ Wolter, J.M.⁸ Steinberg, M.⁹ Webster, A.¹⁰ Lee, D.¹¹

11
- 0028873380
- Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies
- (1995) Am J Pathol , vol.146 , pp. 491-500
- Wanatbe, K.¹ Sasano, H.² Harada, N.³ Ozaki, M.⁴ Niikura, H.⁵ Sata, S.⁶ Yajima, A.⁷

12
- 0024536437
- Optimal two-stage trial design for phase II trials
- (1989) Controlled Clin Trials , vol.10 , pp. 1-20
- Simon, R.¹

13
- 0032377357
- Approximate is better than 'exact' for interval estimation of binomial proportions
- (1998) Am Stat , vol.52 , Issue.2 , pp. 119-126
- Agresti, A.¹ Coull, B.A.²

14
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

15
- 0000336139
- Regression models and life-tables
- (1972) J Stat Soc , vol.34 , pp. 187-220
- Cox, D.R.¹

16
- 0030032844
- High dose megestrol acetate in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- (1996) J Clin Oncol , vol.14 , pp. 357-361
- Lentz, S.¹ Brady, M.² Major, F.J.³ Reid, G.C.⁴ Soper, J.T.⁵

17
- 0033003177
- Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: A dose-response study by the Gynecologic Oncology Group
- (1999) J Clin Oncol , vol.17 , Issue.6 , pp. 1736-1744
- Thigpen Tate¹ Brady, M.² Alvarez, R.D.³ Adelson, M.D.⁴ Homesley, H.D.⁵ Manetta, A.⁶ Soper, J.⁷ Given, F.T.⁸

18
- 0023932927
- Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium
- (1988) Am J Obstet Gynecol , vol.158 , pp. 796-807
- Ehrlich, C.E.¹ Young, P.C.M.² Stehman, F.B.³ Sutton, G.P.⁴ Alford, W.M.⁵

19
- 85031598182
- Physician's Desk Reference, 53rd ed. Montavale, NJ, Medical Economics Company
- (1999) , pp. 3044-3046

20
- 0025727551
- Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions
- (1991) J Clin Oncol , vol.9 , pp. 1071-1088
- Moore, T.D.¹ Phillips, P.H.² Nerenstone, S.R.³ Cheson, B.D.⁴

21
- 0024986437
- Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma: Part I: Clinical and histologic correlations
- (1990) Am J Clin Pathol , vol.94 , pp. 247-254
- Carcangiu, M.L.¹ Chambers, J.T.² Voynick, I.M.³ Pirro, M.⁴ Schwartz, P.E.⁵

22
- 0028269121
- Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors
- (1994) Int J Gynecol Pathol , vol.13 , pp. 127-130
- Umpierre, S.A.¹ Burke, T.W.² Tornos, C.³ Ordonez, N.⁴ Levenback, C.⁵ Morris, M.⁶

23
- 0001534469
- Phase III trial of doxorubicin ± cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study
- abstract 830
- (1993) Proc ASCO , vol.12 , pp. 261
- Thigpen, T.¹ Blessing, J.² Homesley, H.³ Malfetano, J.⁴ DiSaia, P.⁵ Yordan, E.⁶

24
- 0021237994
- Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma
- (1984) Eur J Obstet Gynecol Reprod Biol , vol.17 , pp. 285-291
- Rendina, G.M.¹ Donadio, C.² Fabri, M.³ Mazzoni, P.⁴ Nazzicone, P.⁵

25
- 0024559118
- Tamoxifen therapy in advanced/recurrent endometrial carcinoma
- (1989) Gynecol Oncol , vol.32 , pp. 1-3
- Quinn, M.A.¹ Campbell, J.J.²

26
- 0027962578
- Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types
- (1994) Cancer , vol.74 , pp. 2555-2561
- Imai, A.¹ Ohno, T.² Iida, K.³ Fuseya, T.⁴ Furui, T.⁵ Tamaya, T.⁶

27
- 0031031384
- A phase II study of leuprolide in advanced/recurrent endometrial cancer
- (1997) Gynecol Oncol , vol.64 , pp. 126-129
- Covens, A.¹ Thomas, G.² Shaw, P.³ Ackerman, I.⁴ Osborne, R.⁵ Lukka, H.⁶ Carey, M.⁷ Franssen, E.⁸ Roche, K.⁹

28
- 0030271412
- Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer
- (1996) Gynecol Oncol , vol.63 , pp. 47-52
- Jeyarajah, A.R.¹ Gallagher, C.J.² Blake, P.R.³ Oram, D.H.⁴ Dowsett, M.⁵ Fisher, C.⁶ Oliver, R.T.⁷

29
- 0030930435
- Leuprolide in the treatment of endometrial cancer
- (1997) Gynecol Oncol , vol.66 , pp. 542
- Markman, M.¹ Kennedy, A.² Webster, K.³ Peterson, G.⁴ Kulp, B.⁵ Belinson, J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.